WallStreetZenWallStreetZen

NYSE: TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for TEVA

Based on 4 analysts offering 12 month price targets for TEVA PHARMACEUTICAL INDUSTRIES LTD.
Min Forecast
$7.00-22.57%
Avg Forecast
$10.00+10.62%
Max Forecast
$13.00+43.81%

Should I buy or sell TEVA stock?

Based on 6 analysts offering ratings for TEVA PHARMACEUTICAL INDUSTRIES LTD.
Hold
Strong Buy
1 analysts 16.67%
Buy
0 analysts 0%
Hold
4 analysts 66.67%
Sell
0 analysts 0%
Strong Sell
1 analysts 16.67%

TEVA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Bank of America
Top 23%
78
HoldUpgrades$9.00-0.44%2022-05-17
Anonymous
Goldman Sachs
HoldMaintains$9.00-0.44%2022-05-12
Piper Sandler
Top 15%
86
Strong SellDowngrades$7.00-22.57%2022-05-04
Barclays
Bottom 16%
16
Strong BuyUpgrades$13.00+43.81%2022-04-05
Argus Research
Top 12%
89
HoldDowngradesN/AN/A2022-01-27
Raymond James
Bottom 13%
13
HoldDowngradesN/AN/A2021-10-28
Wells Fargo
Bottom 47%
47
HoldMaintains$11.00+21.68%2021-07-29

1 of 1

Forecast return on equity

Is TEVA forecast to generate an efficient return?
Company
31.61%
Industry
33.3%
Market
31.09%
TEVA's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is TEVA forecast to generate an efficient return on assets?
Company
6.28%
Industry
17.37%
TEVA is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

TEVA earnings per share forecast

What is TEVA's earnings per share in the next 3 years based on estimates from 6 analysts?
Avg 1 year Forecast
$2.40
Avg 2 year Forecast
$2.51
Avg 3 year Forecast
$2.65

TEVA revenue forecast

What is TEVA's revenue in the next 3 years based on estimates from 5 analysts?
Avg 1 year Forecast
$15.7B+0.95%
Avg 2 year Forecast
$16.0B+2.77%
Avg 3 year Forecast
$16.2B+4.22%
TEVA's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

TEVA revenue growth forecast

How is TEVA forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?
Company
1.39%
Industry
7.76%
Market
9.17%
TEVA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
TEVA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

TEVA vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
TEVA$9.04$10.00+10.62%Hold
RDY$56.31$70.00+24.31%Strong Buy
ELAN$23.87$34.33+43.83%Buy
PRGO$40.33$55.50+37.61%Strong Buy
VTRS$12.25$11.33-7.49%Sell
View Top Pharmaceutical Stocks

TEVA PHARMACEUTICAL INDUSTRIES Stock Forecast FAQ

Is TEVA PHARMACEUTICAL INDUSTRIES Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 6 Wall Street analysts covering (NYSE: TEVA) stock is to Hold TEVA stock.

Out of 6 analysts, 1 (16.67%) are recommending TEVA as a Strong Buy, 0 (0%) are recommending TEVA as a Buy, 4 (66.67%) are recommending TEVA as a Hold, 0 (0%) are recommending TEVA as a Sell, and 1 (16.67%) are recommending TEVA as a Strong Sell.

What is TEVA's earnings growth forecast for 2022-2024?

(NYSE: TEVA) TEVA PHARMACEUTICAL INDUSTRIES's forecast annual earnings growth rate of N/A is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast earnings growth rate of 28.96%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.67%.

TEVA PHARMACEUTICAL INDUSTRIES's earnings in 2022 is -$615,000,000.On average, 6 Wall Street analysts forecast TEVA's earnings for 2022 to be $2,664,845,753, with the lowest TEVA earnings forecast at $2,631,535,181, and the highest TEVA earnings forecast at $2,709,259,849. On average, 6 Wall Street analysts forecast TEVA's earnings for 2023 to be $2,786,984,516, with the lowest TEVA earnings forecast at $2,709,259,849, and the highest TEVA earnings forecast at $2,864,709,184.

In 2024, TEVA is forecast to generate $2,942,433,852 in earnings, with the lowest earnings forecast at $2,942,433,852 and the highest earnings forecast at $2,942,433,852.

What is TEVA's revenue growth forecast for 2022-2024?

(NYSE: TEVA) TEVA PHARMACEUTICAL INDUSTRIES's forecast annual revenue growth rate of 1.39% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 7.76%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.17%.

TEVA PHARMACEUTICAL INDUSTRIES's revenue in 2022 is $15,558,000,000.On average, 5 Wall Street analysts forecast TEVA's revenue for 2022 to be $17,439,165,878,120, with the lowest TEVA revenue forecast at $17,257,285,714,081, and the highest TEVA revenue forecast at $17,766,082,492,959. On average, 5 Wall Street analysts forecast TEVA's revenue for 2023 to be $17,753,462,227,614, with the lowest TEVA revenue forecast at $17,189,365,457,957, and the highest TEVA revenue forecast at $18,190,903,320,051.

In 2024, TEVA is forecast to generate $18,004,188,681,676 in revenue, with the lowest revenue forecast at $17,134,958,190,504 and the highest revenue forecast at $18,576,195,601,810.

What is TEVA's forecast return on assets (ROA) for 2022-2025?

(NYSE: TEVA) forecast ROA is 6.28%, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of 17.37%.

What is TEVA's Price Target?

According to 4 Wall Street analysts that have issued a 1 year TEVA price target, the average TEVA price target is $10.00, with the highest TEVA stock price forecast at $13.00 and the lowest TEVA stock price forecast at $7.00.

On average, Wall Street analysts predict that TEVA PHARMACEUTICAL INDUSTRIES's share price could reach $10.00 by May 17, 2023. The average TEVA PHARMACEUTICAL INDUSTRIES stock price prediction forecasts a potential upside of 10.62% from the current TEVA share price of $9.04.

What is TEVA's Earnings Per Share (EPS) forecast for 2022-2024?

(NYSE: TEVA) TEVA PHARMACEUTICAL INDUSTRIES's current Earnings Per Share (EPS) is -$0.55. On average, analysts forecast that TEVA's EPS will be $2.40 for 2022, with the lowest EPS forecast at $2.37, and the highest EPS forecast at $2.44. On average, analysts forecast that TEVA's EPS will be $2.51 for 2023, with the lowest EPS forecast at $2.44, and the highest EPS forecast at $2.58. In 2024, TEVA's EPS is forecast to hit $2.65 (min: $2.65, max: $2.65).

What is TEVA's forecast return on equity (ROE) for 2022-2025?

(NYSE: TEVA) forecast ROE is 31.61%, which is considered strong.
©2022 WallStreetZen
Company
AboutBlogPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContact
Stocks
Stock ScreenerStock ForecastHighest Earnings StocksBest Dividend Paying StocksStatisticsTrending StocksStock Market SectorsStock Market Industries
Analysts
Top Performing Analysts
Social
TwitterYouTube
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.